You are here

  • Home
  • Archive
  • Volume 24, Issue Suppl 1
  • CP-169 Influence of concomitant treatment with statins on survival outcomes of patients with metastatic castration resistant prostate cancer receiving abiraterone as firstline therapy

Article info

Article menu
Download PDFPDF
Clinical pharmacy
CP-169 Influence of concomitant treatment with statins on survival outcomes of patients with metastatic castration resistant prostate cancer receiving abiraterone as firstline therapy

Authors

Citation

Lores MT, Paisán EE, Montero EL, et al
CP-169 Influence of concomitant treatment with statins on survival outcomes of patients with metastatic castration resistant prostate cancer receiving abiraterone as firstline therapy
European Journal of Hospital Pharmacy 2017;24:A76.

Publication history

  • First published February 25, 2017.
Online issue publication 
February 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions